About the role
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
Vir Biotechnology has exclusive rights to the universal PRO-XTEN® masking platform for oncology and infectious disease. PRO-XTEN® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
THE OPPORTUNITY
Reporting to the Chief Medical Officer, or CMO, the SVP Oncology Therapeutic Area Head, or TA Head, will be responsible for overseeing the successful development of multiple molecules for the treatment of cancer in Vir Biotechnology's oncology portfolio. The Oncology TA Head will lead the oncology strategy and lead a cross-functional clinical team to develop novel therapeutics from IND through marketing application and registration. This will include guidance and oversight of clinical development strategies for multiple programs and provision of expert input to clinical developability of pre-clinical assets in the oncology pipeline. The TA head will be a key partner for the Research Organization and will provide clinical and strategic leadership for programs in Discovery through IND filing. The TA Head will also be a key partner for business development in oncology.
This role is located at Vir Bio’s San Francisco headquarters with an expectation of 3 days per week in the office.
WHAT YOU'LL DO
- Lead Vir Bio's Oncology clinical development strategy to deliver registrational data to health authorities for evaluation and, ultimately, to patients and the oncologists who care for them.
- Oversee activities to ensure appropriate objectives and resources are deployed to deliver on key milestones to advance the company’s oncology assets in development.
- Coach and mentor program team leaders, clinical scientists and medical monitors.
- Collaborate with Regulatory Sciences to shape the regulatory strategy for oncology clinical development programs and play a key role in representing the Company in health authority interactions
- Core member of the CMO Organization Leadership Team
- Responsible for collaborating with stakeholders across Vir Bio and with external partners, including potential joint development steering committees, to shape the strategy and efficient advancement of molecules throughout clinical development.
- At major congresses, and as needed, represent the Company and the science to various internal and external stakeholders (including the Board of Directors, clinical investigators, KOLs, patient advocacy groups, investors, and analysts).
WHO YOU ARE AND WHAT YOU BRING
A highly experienced, collaborative, and innovative leader with extensive clinical drug development experience will thrive in this role. A successful candidate will demonstrate strategic and technical prowess, build strong working relationships, and have an entrepreneurial spirit. Specific qualifications include:
- M.D. with specialty training in Oncology required
- Minimum 12+ years of experience in early and late-stage clinical development at biotech or pharmaceutical company required
- Demonstrated track record applying strategic context to development planning, ability to balance risk and make trade-offs to advance the portfolio priorities
- A high degree of business acumen, a big-picture perspective, and the ability to galvanize a team around a common goal
- Demonstrated track record of accountability, scientific rigor, and innovation
- Ability to build teams and a culture that nourishes creativity, scientific curiosity, with integrity and respect across functions and layers within the Company
- An outcome-driven mindset and a commitment to achieving key milestones
- Exceptional interpersonal and communication skills able to clearly convey complex medical and scientific information to a wide range of internal and external audien
WHO WE ARE AND WHAT WE OFFER
Vir Biotechnology's compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes compensation, bonus and equity as well as many other Vir Biotechnology benefits and perks such as health and welfare benefit plans, non-accrual paid time off, company shut down for holidays, commuter benefits, 401K match and lunch each day in the office.
Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to any legally protected characteristics.
This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs. Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful conduct or harassment.
Vir Biotechnology Human Resources leads recruitment and employment for Vir Biotechnology. Unsolicited resumes sent to the company from recruiters do not constitute any type of relationship between the recruiter and Vir Biotechnology and do not obligate us to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.
For hires based in the United States, Vir Biotechnology, participates in E-Verify.
Aplyr's read
Vir Biotechnology is a cutting-edge immunology firm tackling serious infectious diseases, attracting professionals passionate about innovative therapies and vaccine development.
What's promising
- •Strong focus on developing therapies for infectious diseases with significant unmet medical needs.
- •Collaborative culture with opportunities for cross-disciplinary teamwork in immunology.
- •Recent strategic hires indicate growth and commitment to expanding therapeutic areas.
What to watch
- •Clinical-stage status means potential volatility and uncertainty in long-term job stability.
- •Heavy reliance on successful clinical trial outcomes for future growth.
- •Limited public information about financial stability and long-term sustainability.
Why Vir Biotechnology
- •Specializes in leveraging the immune system for innovative treatment solutions.
- •Focus on serious infectious diseases differentiates it from broader biotech firms.
- •Combines cutting-edge research with strategic partnerships to accelerate development.
Aplyr’s read is generated by AI from public sources. Was it useful?
About Vir Biotechnology
Vir Biotechnology is a clinical-stage immunology company focused on treating and preventing serious infectious diseases. The company leverages its expertise in immunology and the immune system to develop therapies and vaccines.
